1-Acetylpiperazine → HCID 86584681, compound
Reaction equation
BrCCO[C:5]1[CH:14]=[C:13]2[C:8]([C:9](NC3C=CC([Cl:22])=CC=3F)=[N:10][CH:11]=[N:12]2)=[CH:7][C:6]=1[O:24][CH3:25].C(N1CCNCC1)(=O)C>C(Cl)Cl.C(OCC)(=O)C>[ClH:22].[CH3:25][O:24][C:6]1[CH:7]=[C:8]2[C:13](=[CH:14][CH:5]=1)[N:12]=[CH:11][N:10]=[CH:9]2Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
7-(2-Bromoethoxy)-4-(4-chloro-2-fluoroanilino)6-methoxyquinazoline (150 mg, 0.35 mmol) and 1-acetylpiperazine (135 mg, 1 mmol) were heated together at 140° C. for 10 minutes. The mixture was allowed to cool and was dissolved in a mixture of methylene chloride/ethyl acetate. The solution was washed with water, and then brine, dried (MgSO4) and the solvent removed by evaporation. The residue was purified by column chromatography eluting with methylene chloride/methanol (9/1). The purified product was dissolved in methylene chloride and 2.9M ethereal hydrogen chloride was added. The precipitate was collected by filtration, washed with ether and dried under vacuum to give 7-(2-(4-acetylpiperazin-1-yl)ethoxy)-44-chloro-2-fluoroanilino)-6-methoxyquinazoline hydrochloride (152 mg, 79%).
Workup
- temperatureto cool
- washThe solution was washed with water
- dry with materialbrine, dried (MgSO4)
- customthe solvent removed by evaporation
- customThe residue was purified by column chromatography
- washeluting with methylene chloride/methanol (9/1)
- dissolutionThe purified product was dissolved in methylene chloride
- addition2.9M ethereal hydrogen chloride was added
- filtrationThe precipitate was collected by filtration
- washwashed with ether
- customdried under vacuum
Sources & evidence
- ORD record
- ord-41a08bcee4ce48df911e3a8f072b069b
- Source dataset
- uspto-grants-2005_05
- Patent number
- US06897210B2
Reaction notes
Loading…